NASDAQ:CDLX Cardlytics (CDLX) Stock Price, News & Analysis $1.40 -0.19 (-11.67%) Closing price 04/4/2025 04:00 PM EasternExtended Trading$1.37 -0.03 (-2.07%) As of 04/4/2025 07:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About Cardlytics Stock (NASDAQ:CDLX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Cardlytics alerts:Sign Up Key Stats Today's Range$1.39▼$1.5650-Day Range$1.40▼$3.9052-Week Range$1.39▼$15.89Volume1.18 million shsAverage Volume1.02 million shsMarket Capitalization$72.92 millionP/E RatioN/ADividend YieldN/APrice Target$6.42Consensus RatingHold Company OverviewCardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.Read More… Remove Ads Cardlytics Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks76th Percentile Overall ScoreCDLX MarketRank™: Cardlytics scored higher than 76% of companies evaluated by MarketBeat, and ranked 112th out of 316 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.1 / 5Analyst RatingHold Consensus RatingCardlytics has received a consensus rating of Hold. The company's average rating score is 2.14, and is based on no buy ratings, 5 hold ratings, and 1 sell rating.Amount of Analyst CoverageCardlytics has only been the subject of 3 research reports in the past 90 days.Read more about Cardlytics' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Cardlytics are expected to decrease in the coming year, from ($1.52) to ($1.70) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cardlytics is -0.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cardlytics is -0.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCardlytics has a P/B Ratio of 0.41. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Cardlytics' valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted16.94% of the float of Cardlytics has been sold short.Short Interest Ratio / Days to CoverCardlytics has a short interest ratio ("days to cover") of 7.7.Change versus previous monthShort interest in Cardlytics has recently decreased by 8.35%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCardlytics does not currently pay a dividend.Dividend GrowthCardlytics does not have a long track record of dividend growth. Sustainability and ESG2.8 / 5Environmental Score-0.67 Percentage of Shares Shorted16.94% of the float of Cardlytics has been sold short.Short Interest Ratio / Days to CoverCardlytics has a short interest ratio ("days to cover") of 7.7.Change versus previous monthShort interest in Cardlytics has recently decreased by 8.35%, indicating that investor sentiment is improving significantly. News and Social Media3.2 / 5News SentimentN/A News SentimentCardlytics has a news sentiment score of 1.84. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.69 average news sentiment score of Business Services companies.Search Interest3 people have searched for CDLX on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Cardlytics to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Cardlytics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $313,759.00 in company stock.Percentage Held by InsidersOnly 4.40% of the stock of Cardlytics is held by insiders.Percentage Held by Institutions68.10% of the stock of Cardlytics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Cardlytics' insider trading history. Receive CDLX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cardlytics and its competitors with MarketBeat's FREE daily newsletter. Email Address CDLX Stock News HeadlinesCardlytics, Inc. (NASDAQ:CDLX) Given Average Rating of "Hold" by BrokeragesMarch 26, 2025 | americanbankingnews.comClass Action Filed Against Cardlytics, Inc. (CDLX) - March 25, 2025 Deadline to Join – Contact Levi & KorsinskyMarch 21, 2025 | globenewswire.comTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.April 5, 2025 | American Alternative (Ad)Cardlytics, Inc. Class Action: Levi & Korsinsky Reminds Cardlytics Investors of the Pending ...March 21, 2025 | gurufocus.comCardlytics, Inc. Class Action: Levi & Korsinsky Reminds Cardlytics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - CDLXMarch 21, 2025 | prnewswire.comShareholders that lost money on Cardlytics, Inc. (CDLX) should contact The Gross Law Firm about pending Class Action - CDLXMarch 20, 2025 | globenewswire.comLost Money on Cardlytics, Inc.(CDLX)? Join Class Action Suit Seeking Recovery - Contact The Gross Law FirmMarch 20, 2025 | prnewswire.comLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in Cardlytics Lawsuit – CDLXMarch 18, 2025 | globenewswire.comSee More Headlines CDLX Stock Analysis - Frequently Asked Questions How have CDLX shares performed this year? Cardlytics' stock was trading at $3.71 at the beginning of the year. Since then, CDLX stock has decreased by 62.3% and is now trading at $1.40. View the best growth stocks for 2025 here. How were Cardlytics' earnings last quarter? Cardlytics, Inc. (NASDAQ:CDLX) issued its earnings results on Wednesday, November, 6th. The company reported ($0.15) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.33) by $0.18. Cardlytics's revenue was down 15.1% compared to the same quarter last year. Does Cardlytics have any subsidiaries? Cardlytics subsidiaries include Bridg, DOSH, Cardlytics Services India Private Limited, and Cardlytics UK Limited. When did Cardlytics IPO? Cardlytics (CDLX) raised $76 million in an IPO on Friday, February 9th 2018. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan acted as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers. How do I buy shares of Cardlytics? Shares of CDLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Cardlytics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cardlytics investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Netflix (NFLX), Tesla (TSLA), Intel (INTC) and Rambus (RMBS). Company Calendar Last Earnings11/06/2024Today4/05/2025Next Earnings (Estimated)4/30/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorBusiness Services Industry Computer programming, data processing, & other computer related Sub-IndustryComputer Software Current SymbolNASDAQ:CDLX CIK1666071 Webwww.cardlytics.com Phone(888) 798-5802FaxN/AEmployees500Year Founded2008Price Target and Rating Average Stock Price Target$6.42 High Stock Price Target$12.00 Low Stock Price Target$3.00 Potential Upside/Downside+358.3%Consensus RatingHold Rating Score (0-4)2.14 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)($3.86) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-134,700,000.00 Net Margins-93.55% Pretax Margin-93.55% Return on Equity-110.67% Return on Assets-32.70% Debt Debt-to-Equity Ratio2.40 Current Ratio1.18 Quick Ratio1.18 Sales & Book Value Annual Sales$278.30 million Price / Sales0.26 Cash Flow$0.59 per share Price / Cash Flow2.36 Book Value$3.43 per share Price / Book0.41Miscellaneous Outstanding Shares52,085,000Free Float48,586,000Market Cap$72.92 million OptionableOptionable Beta1.39 Social Links Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NASDAQ:CDLX) was last updated on 4/5/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredBrace Yourself for Jeff Bezos’ “Amazon Helios”Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredIt’s Time to Buy Elon’s “ChatGPT Killer”Elon Musk’s new AI model is blowing everyone’s mind. It has been called “a game-changer in AI innovation”.....Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardlytics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardlytics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.